Flu Vaccine (Influenza Vaccine) Market Report

Flu Vaccine (Influenza Vaccine) Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 29, 2020
  • PAGES：147
  • REPORT CODE：GMM452838
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Flu Vaccine (Influenza Vaccine) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.9% during the forecast period.

    This report presents the market size and development trends by detailing the Flu Vaccine (Influenza Vaccine) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Flu Vaccine (Influenza Vaccine) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Flu Vaccine (Influenza Vaccine) industry and will help you to build a panoramic view of the industrial development.

    Flu Vaccine (Influenza Vaccine) Market, By Type:

    • Whole Virus Vaccines

    • Split Virus Vaccines

    • Subunit Vaccines

    • Live Attenuated Virus Vaccines

    Flu Vaccine (Influenza Vaccine) Market, By Application:

    • Live Attenuated Virus Vaccines

    • Live Attenuated Virus Vaccines

    • Live Attenuated Virus Vaccines

    Some of the leading players are as follows:

    • GSK

    • Pfizer

    • AstraZeneca

    • CSL

    • Johnson & Johnson

    • Sanofi Pasteur

    • Mylan

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Flu Vaccine (Influenza Vaccine) Market: Technology Type Analysis

    • 4.1 Flu Vaccine (Influenza Vaccine) Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Flu Vaccine (Influenza Vaccine) Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Whole Virus Vaccines

      • 4.3.2 Split Virus Vaccines

      • 4.3.3 Subunit Vaccines

      • 4.3.4 Live Attenuated Virus Vaccines

    5 Flu Vaccine (Influenza Vaccine) Market: Product Analysis

    • 5.1 Flu Vaccine (Influenza Vaccine) Product Market Share Analysis, 2018 & 2026

    • 5.2 Flu Vaccine (Influenza Vaccine) Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Flu Vaccine (Influenza Vaccine) Market: Application Analysis

    • 6.1 Flu Vaccine (Influenza Vaccine) Application Market Share Analysis, 2018 & 2026

    • 6.2 Flu Vaccine (Influenza Vaccine) Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Live Attenuated Virus Vaccines

      • 6.3.2 Live Attenuated Virus Vaccines

      • 6.3.3 Live Attenuated Virus Vaccines

    7 Flu Vaccine (Influenza Vaccine) Market: Regional Analysis

    • 7.1 Flu Vaccine (Influenza Vaccine) Regional Market Share Analysis, 2018 & 2026

    • 7.2 Flu Vaccine (Influenza Vaccine) Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GSK

      • 9.1.1 GSK Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Pfizer

      • 9.2.1 Pfizer Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 AstraZeneca

      • 9.3.1 AstraZeneca Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 CSL

      • 9.4.1 CSL Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Johnson & Johnson

      • 9.5.1 Johnson & Johnson Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Sanofi Pasteur

      • 9.6.1 Sanofi Pasteur Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Mylan

      • 9.7.1 Mylan Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

     

    The List of Tables and Figures (Totals 82 Figures and 136 Tables)

    • Figure Whole Virus Vaccines Flu Vaccine (Influenza Vaccine) market, 2015 - 2026 (USD Million)

    • Figure Split Virus Vaccines Flu Vaccine (Influenza Vaccine) market, 2015 - 2026 (USD Million)

    • Figure Subunit Vaccines Flu Vaccine (Influenza Vaccine) market, 2015 - 2026 (USD Million)

    • Figure Live Attenuated Virus Vaccines Flu Vaccine (Influenza Vaccine) market, 2015 - 2026 (USD Million)

    • Figure Live Attenuated Virus Vaccines market, 2015 - 2026 (USD Million)

    • Figure Live Attenuated Virus Vaccines market, 2015 - 2026 (USD Million)

    • Figure Live Attenuated Virus Vaccines market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Flu Vaccine (Influenza Vaccine) market, by country, 2015 - 2026 (USD Million)

    • Table North America Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table North America Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table North America Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Canada Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Canada Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine (Influenza Vaccine) market, by country, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Europe Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Germany Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Germany Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table France Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table France Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Italy Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Italy Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Spain Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Spain Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine (Influenza Vaccine) market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table China Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table China Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Japan Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Japan Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table India Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table India Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine (Influenza Vaccine) market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine (Influenza Vaccine) market, by country, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table MEA Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Flu Vaccine (Influenza Vaccine) market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Flu Vaccine (Influenza Vaccine) market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Flu Vaccine (Influenza Vaccine) market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CSL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US